Literature DB >> 18496208

PDLIM5 and susceptibility to bipolar disorder: a family-based association study and meta-analysis.

Jiajun Shi1, Judith A Badner, Chunyu Liu.   

Abstract

OBJECTIVES: The postsynaptic density-95/discs large/zone occludens-1 (PDZ) domain and LIM (Lin-11, Isl-1, and Mec-3) domain 5 (PDLIM5) gene has been analyzed as a candidate gene for both schizophrenia and bipolar disorder (BP) in Japanese samples. We performed a family-based association study to test the hypothesis that variants in PDLIM5 increase susceptibility to BP in European-Americans and a meta-analysis to clarify whether there is a single marker consistently contributing to risk for BP.
METHODS: Five single nucleotide polymorphisms in the PDLIM5 gene were genotyped in 290 European-American BP families. Programs Sibling-Transmission/Disequilibrium Test (sib_tdt) and PDTPHASE were used for allelic and haplotypic association, respectively. We carried out a meta-analysis combing our family-based data and case-control data from two Japanese sample sets and from two genome-wide association (GWA) studies.
RESULTS: Our association analysis showed no single nucleotide polymorphism associated with BP. A rare haplotype consisted of rs10008257 and rs2433320 had nominal association (P=0.045), which failed to survive correction for multiple tests. The meta-analysis identified a significant allelic association at rs2433320 in all combined samples (excluding overlapped samples in GWA: overall odds ratio=0.897, 95% confidence interval: 0.838-0.961, adjusted P=0.012) and in all Caucasian samples (excluding overlapped samples in GWA: overall odds ratio=0.905, 95% confidence interval: 0.843-0.971, adjusted P=0.032), but not in the Japanese samples.
CONCLUSION: PDLIM5 may have a minor effect on susceptibility to BP in Caucasians. The findings in Japanese need further confirmation in larger independent samples.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18496208      PMCID: PMC2572255          DOI: 10.1097/YPG.0b013e3282fa184b

Source DB:  PubMed          Journal:  Psychiatr Genet        ISSN: 0955-8829            Impact factor:   2.458


  34 in total

1.  Second stage of a genome scan of schizophrenia: study of five positive regions in an expanded sample.

Authors:  B J Mowry; K R Ewen; D J Nancarrow; D P Lennon; D A Nertney; H L Jones; M S O'Brien; C E Thornley; M K Walters; R R Crowe; J M Silverman; J Endicott; L Sharpe; N K Hayward; M M Gladis; S J Foote; D F Levinson
Journal:  Am J Med Genet       Date:  2000-12-04

2.  Inference of population structure using multilocus genotype data.

Authors:  J K Pritchard; M Stephens; P Donnelly
Journal:  Genetics       Date:  2000-06       Impact factor: 4.562

3.  Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium.

Authors:  Christopher S Carlson; Michael A Eberle; Mark J Rieder; Qian Yi; Leonid Kruglyak; Deborah A Nickerson
Journal:  Am J Hum Genet       Date:  2003-12-15       Impact factor: 11.025

Review 4.  The allelic architecture of human disease genes: common disease-common variant...or not?

Authors:  Jonathan K Pritchard; Nancy J Cox
Journal:  Hum Mol Genet       Date:  2002-10-01       Impact factor: 6.150

5.  Pedigree disequilibrium tests for multilocus haplotypes.

Authors:  Frank Dudbridge
Journal:  Genet Epidemiol       Date:  2003-09       Impact factor: 2.135

6.  PEDSTATS: descriptive statistics, graphics and quality assessment for gene mapping data.

Authors:  Janis E Wigginton; Gonçalo R Abecasis
Journal:  Bioinformatics       Date:  2005-06-09       Impact factor: 6.937

7.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

8.  Isolation, tissue expression, and chromosomal assignment of a human LIM protein gene, showing homology to rat enigma homologue (ENH).

Authors:  N Ueki; N Seki; K Yano; Y Masuho; T Saito; M Muramatsu
Journal:  J Hum Genet       Date:  1999       Impact factor: 3.172

9.  Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL.

Authors:  Stefano Romeo; Len A Pennacchio; Yunxin Fu; Eric Boerwinkle; Anne Tybjaerg-Hansen; Helen H Hobbs; Jonathan C Cohen
Journal:  Nat Genet       Date:  2007-02-25       Impact factor: 38.330

10.  Gene expression in the peripheral leukocytes and association analysis of PDLIM5 gene in schizophrenia.

Authors:  Shusuke Numata; Shu-ichi Ueno; Jun-ichi Iga; Ken Yamauchi; Song Hongwei; Ryota Hashimoto; Masatoshi Takeda; Hiroshi Kunugi; Mitsuo Itakura; Tetsuro Ohmori
Journal:  Neurosci Lett       Date:  2007-01-11       Impact factor: 3.046

View more
  6 in total

Review 1.  Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome.

Authors:  Anamika Banerjee; Mathew L Macdonald; Karin E Borgmann-Winter; Chang-Gyu Hahn
Journal:  Brain Res Bull       Date:  2010-04-28       Impact factor: 4.077

2.  High-resolution chromosome ideogram representation of recognized genes for bipolar disorder.

Authors:  Lindsay N Douglas; Austen B McGuire; Ann M Manzardo; Merlin G Butler
Journal:  Gene       Date:  2016-04-07       Impact factor: 3.688

3.  Meta-analysis of haplotype-association studies: comparison of methods and empirical evaluation of the literature.

Authors:  Pantelis G Bagos
Journal:  BMC Genet       Date:  2011-01-19       Impact factor: 2.797

4.  Experimental evidence for the involvement of PDLIM5 in mood disorders in hetero knockout mice.

Authors:  Yasue Horiuchi; Maya Ishikawa; Nobuko Kaito; Yoshimi Iijima; Yoshiko Tanabe; Hiroki Ishiguro; Tadao Arinami
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

5.  Peripheral PDLIM5 expression in bipolar disorder and the effect of olanzapine administration.

Authors:  Mohd Aizat Zain; Suffee Nusrat Jahan; Gavin P Reynolds; Nor Zuraida Zainal; Sharmilla Kanagasundram; Zahurin Mohamed
Journal:  BMC Med Genet       Date:  2012-10-02       Impact factor: 2.103

Review 6.  Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models.

Authors:  James N Samsom; Albert H C Wong
Journal:  Front Psychiatry       Date:  2015-02-18       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.